Learn the basics of embedded systems hacking with Arduino, Raspberry Pi & RTOS. Discover GPIO, interrupts, hands-on projects ...
As Tubulis prepares to unveil the first in-human data on its next-generation antibody drug conjugate (ADC) later this month, ...
After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...
French drugmaker Sanofi has halted the development of its antibody-drug conjugate (ADC) tusamitamab ravtansine after the drug failed a phase 3 trial in non-small cell lung cancer (NSCLC). The drug, ...
The German biotech banked one of the larger funding rounds this year to support an ovarian and non-small cell lung cancer ...
Trial initiation triggered a $250 million payment to SystImmune from Bristol Myers Squibb, under a 2023 collaboration and license agreement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback